NAT1 and cancer: As metabolic reprogramming is one of the hallmarks of cancer proposed by Hanahan and Weinberg14 and acetyl-CoA plays a central role in metabolism15 we have utilized untargeted metabolomics to investigate how different levels of NAT1 affect cellular metabolism in MDA-MB-231 triple negative breast cancer cells.